Fierce Healthcare September 13, 2021
Robert King

The Biden administration wants to pull a controversial Trump-era regulation that would hasten Medicare coverage of breakthrough devices, handing the insurance industry a win.

The Centers for Medicare & Medicaid Services (CMS) issued Monday a proposed rule that would withdraw the rule that creates a new pathway that mandates Medicare coverage as soon as a breakthrough medical device is authorized by the Food and Drug Administration. CMS said the pathway could lead Medicare to cover unnecessary products.

The agency had “significant concerns” about the availability of clinical evidence of breakthrough medical devices when used on the Medicare patient population “as well as the benefit or risks of these devices with respect to use in the Medicare population upon receipt of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Insurance, Medical Devices, Medicare, Regulations
Healthcare Docket: Feds and States Move to Curb Private Equity’s Takeover of Healthcare
CMS releases Medicaid payment flexibilities during Change cyberattack
A New Kind of Hospital Is Coming to Rural America
Improving Hospital Compliance With Price Transparency Rules
Government watchdog warns of Medicaid oversight gaps

Share This Article